PRKCB and diabetic retinopathy: Under diabetic conditions, DAG levels increase and PRKCB2 is hyperactivated, leading to hyperpermeability of retinal vessels and edema, resulting in a clinical conditions namely diabetic retinopathy (DR) (Suzuma et al, 2002; Bourhill et al, 2017).